Thalidomide for inflammatory bowel disease: Systematic review

BACKGROUND: Thalidomide is an immunomodulatory drug used in the experimental treatment of refractory Crohn disease and ulcerative colitis. We aimed to review the existing evidence on the efficacy and safety of thalidomide in the treatment of inflammatory bowel diseases. METHODS: CENTRAL, MEDLINE, LI...

Descripción completa

Detalles Bibliográficos
Autores principales: Bramuzzo, Matteo, Ventura, Alessandro, Martelossi, Stefano, Lazzerini, Marzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265832/
https://www.ncbi.nlm.nih.gov/pubmed/27472695
http://dx.doi.org/10.1097/MD.0000000000004239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265832/
https://www.ncbi.nlm.nih.gov/pubmed/27472695
http://dx.doi.org/10.1097/MD.0000000000004239

Ejemplares similares